Research Insight
AstraZeneca’s type 2 diabetes treatment Xigduo XR obtains FDA...
British-Swedish drugmaker AstraZeneca has received approval from US Food and Drug Administration (FDA) for its once-daily Xigduo XR to treat adult patients with...
Research Insight
Pfizer’s Trumenba gets FDA accelerated approval to treat Meningococcal...
US-based drugmaker Pfizer has received accelerated approval from US Food and Drug Administration (FDA) for its Trumenba to treat Meningococcal B disease in...
Research Insight
Hikma to market Eisai’s epilepsy treatment Fycompa in Middle...
UK-based Hikma Pharmaceuticals has partnered with Eisai to distribute first-class epilepsy treatment Fycompa (perampanel) in the Middle East. Eisai has...
Research Insight
Gilead’s Harvoni receives FDA approval for hepatitis C genotype...
Gilead Sciences has received approval from US Food and Drug Administration for Harvoni (ledipasvir 90mg/sofosbuvir 400mg), a once-daily single tablet regimen to treat...
Research Insight
EMD Serono, ICR and Wellcome Trust partner develop anti-cancer...
Merck subsidiary EMD Serono, The Institute of Cancer Research (ICR) and the Wellcome Trust have entered into a co-development and licence agreement for...
Research Insight
UK’s Medical Research Council grants fund for three new...
The UK Medical Research Council (MRC) has granted a fund of £6m for three new research programmes, as part of a £60m investment. The ...
Research Insight
Novartis and BMS enter clinical collaboration to assess lung...
Swiss drug maker Novartis has partnered with US-based Bristol-Myers Squibb (BMS) to assess the safety, tolerability and preliminary efficacy of its three molecularly...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.